65.03MMarket Cap-1.23P/E (TTM)
5.250High4.745Low9.72KVolume5.250Open4.960Pre Close47.87KTurnover0.23%Turnover RatioLossP/E (Static)13.44MShares19.99952wk High0.63P/B20.24MFloat Cap4.57552wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM10.18%Amplitude4.575Historical Low4.926Avg Price1Lot Size
OnKure Therapeutics Stock Forum
OnKure Q4 Earnings: $110.8M Cash Position Powers Clinical Trial Progress
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet